StockWatch
·
Biotechnology: Pharmaceutical Preparations
Corporate ActionJul 2, 2026, 04:14 PM

Veru Inc. Establishes $21.8M At-The-Market Equity Program

AI Summary

Veru Inc. has established an "at the market" equity offering program by entering into a Sales Agreement with Oppenheimer & Co. Inc. and Canaccord Genuity LLC. This agreement, effective July 2, 2026, allows the company to sell up to $21,800,000 of its common stock from time to time. The company will pay the sales agents a commission of 3.0% on the gross proceeds from each sale.

Key Highlights

  • Veru Inc. entered into a Sales Agreement on July 2, 2026.
  • The agreement allows the company to sell up to $21,800,000 of common stock.
  • Oppenheimer & Co. Inc. and Canaccord Genuity LLC will act as sales agents.
  • Sales will be conducted as "at the market offerings" from time to time.
  • Veru Inc. will pay a commission of 3.0% of the aggregate gross proceeds from sales.